Well Done LLC’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $339K | Sell |
937
-145
| -13% | -$49.6K | 0.05% | 156 |
|
|
2026
Q1 | $381K | Sell |
1,082
-74
| -6% | -$26.4K | 0.06% | 140 |
|
|
2025
Q4 | $378K | Buy |
1,156
+48
| +4% | +$15.2K | 0.06% | 138 |
|
|
2025
Q3 | $313K | Sell |
1,108
-2
| -0.2% | -$580 | 0.05% | 144 |
|
|
2025
Q2 | $310K | Sell |
1,110
-244
| -18% | -$69.1K | 0.06% | 136 |
|
|
2025
Q1 | $353K | Sell |
1,354
-1
| -0.1% | -$295 | 0.06% | 125 |
|
|
2024
Q4 | $437K | Hold |
1,355
| – | – | 0.08% | 116 |
|
|
2024
Q3 | $437K | Sell |
1,355
-87
| -6% | -$28.5K | 0.08% | 117 |
|
|
2024
Q2 | $451K | Sell |
1,442
-982
| -41% | -$288K | 0.09% | 118 |
|
|
2024
Q1 | $689K | Buy |
2,424
+120
| +5% | +$35.1K | 0.14% | 90 |
|
|
2023
Q4 | $664K | Buy |
2,304
+31
| +1% | +$8.45K | 0.13% | 88 |
|
|
2023
Q3 | $611K | Sell |
2,273
-7
| -0.3% | -$1.75K | 0.14% | 85 |
|
|
2023
Q2 | $506K | Sell |
2,280
-315
| -12% | -$73.1K | 0.11% | 99 |
|
|
2023
Q1 | $627K | Buy |
2,595
+112
| +5% | +$27.5K | 0.14% | 85 |
|
|
2022
Q4 | $652K | Buy |
2,483
+83
| +3% | +$22.2K | 0.14% | 83 |
|
|
2022
Q3 | $541K | Buy |
2,400
+126
| +6% | +$30.5K | 0.13% | 83 |
|
|
2022
Q2 | $553K | Hold |
2,274
| – | – | 0.12% | 91 |
|
|
2022
Q1 | $550K | Hold |
2,274
| – | – | 0.11% | 103 |
|
|
2021
Q4 | $512K | Sell |
2,274
-25
| -1% | -$5.28K | 0.1% | 106 |
|
|
2021
Q3 | $489K | Buy |
2,299
+4
| +0.2% | +$921 | 0.11% | 109 |
|
|
2021
Q2 | $559K | Buy |
2,295
+6
| +0.3% | +$1.48K | 0.12% | 97 |
|
|
2021
Q1 | $570K | Buy |
2,289
+148
| +7% | +$35.3K | 0.13% | 92 |
|
|
2020
Q4 | $492K | Buy |
2,141
+1,007
| +89% | +$232K | 0.12% | 88 |
|
|
2020
Q3 | $288K | Hold |
1,134
| – | – | 0.08% | 110 |
|
|
2020
Q2 | $267K | Hold |
1,134
| – | – | 0.07% | 122 |
|
|
2020
Q1 | $230K | Hold |
1,134
| – | – | 0.07% | 121 |
|
|
2019
Q4 | $273K | Sell |
1,134
-207
| -15% | -$45.6K | 0.06% | 124 |
|
|
2019
Q3 | $259K | Buy |
+1,341
| New | +$257K | 0.06% | 129 |
|
|
2019
Q1 | – | Sell |
-273
| Closed | -$53K | – | 167 |
|
|
2018
Q4 | $53K | Buy |
+273
| New | +$53.3K | 0.01% | 257 |
|
|
2018
Q2 | – | Sell |
-271
| Closed | -$46K | – | 147 |
|
|
2018
Q1 | $46K | Buy |
+271
| New | +$49.7K | 0.01% | 233 |
|
Other funds holding AMGN
Well Done LLC's AMGN Position: Q2 2026 in Review
Well Done LLC reduced its Amgen (AMGN) stake by 13% in Q2 2026, selling an estimated $49.6K and leaving 937 shares worth $339K. The position accounts for 0.05% of the portfolio, ranked #156.
Well Done LLC first reported a position in AMGN in Q1 2018 and has held it in 30 quarters since. The position peaked at $689K in Q1 2024. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Well Done LLC held 937 shares of Amgen worth $339K as of Q2 2026.
- Well Done LLC sold 145 Amgen shares in Q2 2026, an estimated $49.6K.
- Amgen made up 0.05% of Well Done LLC's portfolio in Q2 2026, its #156 holding.
- Well Done LLC first reported a position in Amgen in Q1 2018 and has held it in 30 quarters since.
- Well Done LLC's Amgen position peaked at $689K in Q1 2024.
- 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Well Done LLC's 13F filing for Q2 2026, filed 24 Jul 2026.